citalopram has been researched along with vortioxetine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 17 (62.96) | 24.3611 |
2020's | 10 (37.04) | 2.80 |
Authors | Studies |
---|---|
Bang-Andersen, B; Frederiksen, K; Hogg, S; Jensen, KG; Jørgensen, M; Mørk, A; Nielsen, SM; Ruhland, T; Smith, G; Stensbøl, TB; Zhong, H | 1 |
Bang-Andersen, B; Boyle, NJ; Brennum, LT; Bundgaard, C; Fischer, CW; Hogg, S; Lassen, AB; Liebenberg, N; Miller, S; Mørk, A; Nielsen, SM; Pehrson, A; Sánchez, C; Stensbøl, TB; Wegener, G; Westrich, L; Zhong, H | 1 |
Bétry, C; Cremers, T; Ebert, B; Haddjeri, N; Jørgensen, L; Madsen, M; Pehrson, AL; Sanchez, C; van der Hart, MG | 1 |
Budac, D; du Jardin, KG; Jensen, JB; Pehrson, AL; Sanchez, C; Smagin, G; Song, D | 1 |
Leiser, SC; Pehrson, AL; Robichaud, PJ; Sanchez, C | 1 |
Dale, E; Leiser, SC; Lu, D; Plath, N; Sanchez, C; Xiao, Y; Yang, CR; Zhang, H | 1 |
Brignone, M; Ereshefsky, L; Francois, C; Lançon, C; Llorca, PM; Rive, B; Salah, S | 1 |
Chen, Y; Chrones, L; Clayton, AH; Jacobsen, PL; Mahableshwarkar, AR | 1 |
Papakostas, GI | 1 |
Bundgaard, C; Eneberg, E; Sánchez, C | 1 |
Fuller, RR; Hughes, S; Lacasse, J; Spaulding-Givens, J | 1 |
Olsen, CK; Sluth, LB; Vieta, E | 1 |
Christensen, SR; Danjou, P; Ganz, M; Gram, M; Ip, CT; Knudsen, GM; l'Hostis, P; Ozenne, B; Sluth, LB; Viardot, G | 1 |
Christensen, MC; McIntyre, RS; Sluth, LB | 1 |
Levada, OA; Troyan, AS | 1 |
Roselle, A | 1 |
Affinito, J; Clayton, A; Cutler, AJ; Jacobsen, PL; Nomikos, GG; Zhong, W | 1 |
Bastlund, JF; Christensen, SR; Danjou, P; Drewes, AM; Gram, M; l'Hostis, P; Laursen, B; Nissen, TD; Sluth, LB; Viardot, G | 1 |
Fukuyama, K; Okada, M; Okubo, R | 1 |
Artigas, F; Celada, P; Riga, MS; Sanchez, C | 1 |
Dvojkovic, A; Jaksic, N; Kusevic, Z; Mihaljevic-Peles, A; Nikolac Perkovic, M; Pivac, N; Sagud, M; Vuksan-Cusa, B; Zivkovic, M | 1 |
Fukuyama, K; Matsumoto, R; Okada, M; Yamamoto, Y | 1 |
Danielak, D | 1 |
Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
Fukuyama, K; Okada, M; Shiroyama, T | 1 |
Cipelli, R; Dell'Osso, B; Di Nicola, M; Martinotti, G; Peduto, I; Pugliese, AC; Signorelli, MS; Ventriglio, A | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
4 review(s) available for citalopram and vortioxetine
Article | Year |
---|---|
Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Benzofurans; Citalopram; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Humans; Hypnotics and Sedatives; Indoles; Male; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfides; Thiophenes; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2014 |
Antidepressants and their effect on cognition in major depressive disorder.
Topics: Adult; Citalopram; Cognition Disorders; Depressive Disorder, Major; Duloxetine Hydrochloride; Executive Function; Humans; Middle Aged; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sulfides; Vortioxetine | 2015 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
7 trial(s) available for citalopram and vortioxetine
Article | Year |
---|---|
Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Canada; Citalopram; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sexual Behavior; Sexual Dysfunctions, Psychological; Sulfides; Surveys and Questionnaires; Treatment Outcome; United States; Vortioxetine; Young Adult | 2015 |
The effects of vortioxetine on cognitive dysfunction in patients with inadequate response to current antidepressants in major depressive disorder: A short-term, randomized, double-blind, exploratory study versus escitalopram.
Topics: Adult; Antidepressive Agents; Citalopram; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Sulfides; Treatment Outcome; Vortioxetine; Young Adult | 2018 |
Pre-intervention test-retest reliability of EEG and ERP over four recording intervals.
Topics: Adult; Brain Waves; Citalopram; Cross-Over Studies; Double-Blind Method; Electroencephalography; Event-Related Potentials, P300; Evoked Potentials; Evoked Potentials, Auditory; Humans; Male; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Time Factors; Vortioxetine; Young Adult | 2018 |
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram.
Topics: Adult; Anhedonia; Antidepressive Agents; Citalopram; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Efficiency; Female; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Neuropsychological Tests; Treatment Outcome; Ukraine; Vortioxetine; Young Adult | 2019 |
Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
Topics: Adult; Citalopram; Depression; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Vortioxetine | 2020 |
Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings - A Randomized, Crossover Trial in Healthy Males.
Topics: Adult; Brain; Citalopram; Cross-Over Studies; Double-Blind Method; Electroencephalography; Healthy Volunteers; Humans; Male; Middle Aged; Nerve Net; Selective Serotonin Reuptake Inhibitors; Vortioxetine; Young Adult | 2020 |
Distinct association of plasma BDNF concentration and cognitive function in depressed patients treated with vortioxetine or escitalopram.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cognition; Cognitive Dysfunction; Depressive Disorder, Major; Female; Humans; Male; Memory, Short-Term; Middle Aged; Vortioxetine; Young Adult | 2021 |
16 other study(ies) available for citalopram and vortioxetine
Article | Year |
---|---|
Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
Topics: Animals; Antidepressive Agents; Cell Line; Depressive Disorder, Major; Drug Partial Agonism; Drug Stability; Hippocampus; Humans; In Vitro Techniques; Microsomes, Liver; Oocytes; Piperazines; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Recombinant Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Sulfides; Vortioxetine; Xenopus | 2011 |
Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder.
Topics: Animals; Anti-Anxiety Agents; Biogenic Monoamines; Citalopram; Depressive Disorder, Major; Humans; Male; Ondansetron; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Reflex; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vocalization, Animal; Vortioxetine | 2012 |
Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters--a rat microdialysis and electrophysiology study.
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Citalopram; Dose-Response Relationship, Drug; Hippocampus; Locus Coeruleus; Male; Neurons; Neurotransmitter Agents; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Sulfides; Ventral Tegmental Area; Vortioxetine | 2013 |
Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation.
Topics: 5-Hydroxytryptophan; Animals; Carbidopa; Citalopram; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Exploratory Behavior; Female; Hippocampus; Maze Learning; Memory Disorders; Phenylalanine; Piperazines; Protein Binding; Rats; Rats, Long-Evans; Recognition, Psychology; Selective Serotonin Reuptake Inhibitors; Serotonin; Sulfides; Thiophenes; Vortioxetine | 2014 |
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.
Topics: Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Electroencephalography; Frontal Lobe; Male; Piperazines; Rats, Sprague-Dawley; Receptors, Serotonin; RNA-Binding Proteins; Sulfides; Thiophenes; Vortioxetine; Wakefulness | 2014 |
Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus.
Topics: Animals; Antidepressive Agents; CA1 Region, Hippocampal; Citalopram; Frontal Lobe; Inhibitory Postsynaptic Potentials; Neuronal Plasticity; Piperazines; Pyramidal Cells; Rats; Serotonin; Serotonin Antagonists; Sulfides; Synaptic Transmission; Theta Rhythm; Vortioxetine | 2014 |
P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood-brain barrier in vivo.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain Chemistry; Cerebral Cortex; Citalopram; Cyclopropanes; Male; Mice; Milnacipran; Piperazines; Serotonin Plasma Membrane Transport Proteins; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2016 |
Adverse effects and treatment satisfaction among online users of four antidepressants.
Topics: Affective Symptoms; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Humans; Internet; Mental Disorders; Patient Satisfaction; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine | 2017 |
Validation of the University of California San Diego Performance-based Skills Assessment (UPSA) in major depressive disorder: Replication and extension of initial findings.
Topics: Activities of Daily Living; Adult; Aged; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychometrics; Randomized Controlled Trials as Topic; Surveys and Questionnaires; Vortioxetine | 2019 |
Escitalopram related edema in a patient with Hashimoto's thyroiditis.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Citalopram; Depression; Edema; Female; Hashimoto Disease; Humans; Vortioxetine | 2019 |
Vortioxetine Subchronically Activates Serotonergic Transmission via Desensitization of Serotonin 5-HT
Topics: Animals; Citalopram; gamma-Aminobutyric Acid; Male; Prefrontal Cortex; Rats; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Vortioxetine | 2019 |
Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Circadian Rhythm; Citalopram; Fenclonine; Male; Memory Disorders; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Vortioxetine | 2020 |
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Cerebral Cortex; Citalopram; Glutamic Acid; Lurasidone Hydrochloride; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Thalamus; Vortioxetine | 2021 |
Vortioxetine in management of major depressive disorder - a favorable alternative for elderly patients?
Topics: Aged; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Humans; Selective Serotonin Reuptake Inhibitors; Sulfides; Vortioxetine | 2021 |
Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43.
Topics: Animals; Astrocytes; Chromatography, High Pressure Liquid; Citalopram; Connexin 43; Depression; Female; Immunoblotting; Rats; Receptors, Serotonin; Vortioxetine | 2021 |
Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Humans; Italy; Paroxetine; Retrospective Studies; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |